Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Aug 3, 2023 · 10-Q · 34 days after period end · 0001213900-23-062782
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$11.29M | -$8.54M | -$12.78M | -$7.14M |
| EPS Diluted | -$1.00 | -$0.76 | -$1.14 | -$1.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end
